The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism. - Franzen,C.A.; Amargo,E.; Todorovic,V.; Desai,B.V.; Huda,S.; Mirzoeva,S.; Chiu,K.; Grzybowski,B.A.; Chew,T.L.; Green,K.J.; Pelling,J.C. (Cancer Prev Res (Phila Pa), 2009)